Serum Endoglin Levels in Patients Suffering from Systemic Sclerosis and Elevated Systolic Pulmonary Arterial Pressure

Figure 1

Eng levels in SSc with elevated sPAP, without elevated sPAP, and in healthy controls. Serum levels of Eng in patients with SSc and elevated sPAP, SSc without elevated sPAP, and healthy control subjects (mean ± SE). Mean serum levels were statistically higher in the SSc group compared to the control group (SSc group cf healthy controls 𝑃=.0028; SSc with elevated sPAP cf SSc without elevated sPAP ^∗𝑃=.2447; SSc without elevated sPAP cf healthy controls ^∗∗𝑃=.057; SSc with elevated sPAP cf healthy controls ^∗∗∗𝑃=.0006).